← Leaderboards
Timothy J Cardozo
New York University School Of Medicine
$14,196,646
Attributed
$20,481,743
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,481,743 · 10
By mechanism
R01$8,710,631 · 3
DP1$4,714,205 · 1
DP2$3,051,000 · 1
RC2$2,093,862 · 1
R21$1,912,045 · 4
Top collaborators
- Leslie Ina Gold9 shared
- Bo R Rueda9 shared
- Xiangpeng Kong5 shared
- Mohamed Boutjdir4 shared
- Avi Ma'Ayan1 shared
- Maxim Totrov1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jill P Buyon$29,367,681
- Leslie Ina Gold$5,621,772
- Bradley W Jones$988,912
- Peter Izmirly$3,742,276
- Wilnelly Martinez-Ortiz$163,379
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularDesignEpitopesAntigensScaffoldSurfaceVaccinesAntibodiesBaseTechnologyHiv VaccineProteinsIn VivoRecording Of Previous EventsGlycoproteinsMediatingAids/Hiv ProblemProgramsPharmaceutical PreparationsComplexEventHiv InfectionsAntibody ResponseInnovation
Grant awards (39)
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides$538,891
R01 · FY2025 · HL
Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apex$211,875
R21 · FY2025 · AI · contact PI
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides$533,948
R01 · FY2024 · HL
Synergizing neutralization and non-neutralization antibody targets at the HIV/SIV viral spike apex$228,825
R21 · FY2024 · AI · contact PI
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides$592,217
R01 · FY2023 · HL
Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides$644,891
R01 · FY2022 · HL
Discovery of novel openers of the understudied human drug target Kir6.1$466,125
R21 · FY2022 · TR · contact PI
ADE-minimized COVID-19 vaccine via epitope focusing and anti-inflammatory innate immunity$466,125
R21 · FY2020 · AI · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$581,460
R01 · FY2018 · CA
Combined cocaine and HIV vaccine$847,500
DP1 · FY2017 · DA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$579,879
R01 · FY2017 · CA
Epitope optimization for heterologous prime-boost HIV vaccines$211,875
R21 · FY2017 · AI · contact PI
Epitope optimization for heterologous prime-boost HIV vaccines$72,970
R21 · FY2017 · AI · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$60,511
R01 · FY2017 · CA
Combined cocaine and HIV vaccine$19,334
DP1 · FY2017 · DA · contact PI
Combined cocaine and HIV vaccine$839,025
DP1 · FY2016 · DA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$583,157
R01 · FY2016 · CA
Combined cocaine and HIV vaccine$271,115
DP1 · FY2016 · DA · contact PI
Epitope optimization for heterologous prime-boost HIV vaccines$254,250
R21 · FY2016 · AI · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$79,392
R01 · FY2016 · CA
Combined cocaine and HIV vaccine$40,680
DP1 · FY2016 · DA · contact PI
Combined cocaine and HIV vaccine$12,721
DP1 · FY2016 · DA · contact PI
Combined cocaine and HIV vaccine$913,735
DP1 · FY2015 · DA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$586,799
R01 · FY2015 · CA
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$79,392
R01 · FY2015 · CA
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$12,996
R01 · FY2015 · CA
Combined cocaine and HIV vaccine$9,763
DP1 · FY2015 · DA · contact PI
Combined cocaine and HIV vaccine$847,500
DP1 · FY2014 · DA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$639,657
R01 · FY2014 · CA
Structure Based Characterization of gp120 Non-V3 Variable Loop Epitopes$623,565
R01 · FY2014 · AI · contact PI
Chemical Biology Design For Malaria$508,500
DP2 · FY2014 · OD · contact PI
Combined cocaine and HIV vaccine$65,332
DP1 · FY2014 · DA · contact PI
Combined cocaine and HIV vaccine$847,500
DP1 · FY2013 · DA · contact PI
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes$759,805
R01 · FY2012 · AI · contact PI
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes$585,681
R01 · FY2011 · AI · contact PI
A Chemical Biology Network for Personalized Medicine$2,093,862
RC2 · FY2010 · LM · contact PI
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes$602,465
R01 · FY2010 · AI · contact PI
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes$625,925
R01 · FY2009 · AI · contact PI
Chemical Biology Design For Malaria$2,542,500
DP2 · FY2008 · OD · contact PI